Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy OpGen stock

Learn how to easily invest in OpGen stock.

OpGen Inc
+ $0.0002 ( + 0.07%)

OpGen Inc is a diagnostics & research business based in the US. OpGen shares (OPGN) are listed on the NASDAQ and all prices are listed in US Dollars. OpGen employs 91 staff and has a trailing 12-month revenue of around $4.1 million.

How to buy shares in OpGen

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – OPGN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

OpGen stock price (NASDAQ: OPGN)

Use our graph to track the performance of OPGN stocks over time.

OpGen shares at a glance

Information last updated 2022-09-23.
Latest market close$0.29
52-week range$0.31 - $3.55
50-day moving average $0.50
200-day moving average $0.69
Wall St. target price$1.84
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-0.83

Buy OpGen shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy OpGen stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

OpGen price performance over time

Historical closes compared with the close of $0.2862 from 2022-09-30

1 week (2022-09-23) -26.08%
1 month (2022-08-30) -40.36%
3 months (2022-07-01) -49.97%
6 months (2022-04-01) -61.97%
1 year (2021-10-01) -89.63%
2 years (2020-10-02) -86.69%
3 years (2019-10-02) 6.84
5 years (2017-09-29) 0.31

OpGen financials

Revenue TTM $4.1 million
Gross profit TTM $-9,453,096
Return on assets TTM -23.42%
Return on equity TTM -76.05%
Profit margin 0%
Book value $0.59
Market capitalisation $18.7 million

TTM: trailing 12 months

OpGen share dividends

We're not expecting OpGen to pay a dividend over the next 12 months.

Have OpGen's shares ever split?

OpGen's shares were split on a 1:20 basis on 28 August 2019. So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your OpGen shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for OpGen shares which in turn could have impacted OpGen's share price.

OpGen share price volatility

Over the last 12 months, OpGen's shares have ranged in value from as little as $0.31 up to $3.55. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OpGen's is -0.3759. This would suggest that OpGen's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, OpGen has bucked the trend.

OpGen overview

OpGen, Inc. , a precision medicine company, engages in developing and commercializing molecular microbiology solutions in the United States and internationally. Its product portfolio includes Acuitas AMR Gene Panel, an in vitro diagnostic (IVD) test for the detection and identification of various bacterial nucleic acids and genetic determinants of antimicrobial resistance (AMR) from bacterial colonies isolated from any specimen, as well as Curetis CE-IVD-marked polymerase chain reaction-based SARS-CoV-2 test kits. The company's products also comprise ARES Technology Platform, including ARES reference database on antimicrobial resistance using next generation sequencing technology and artificial intelligence powered bioinformatics solutions for antibiotic response prediction; and Unyvero Platform, an automated sample-to-answer molecular diagnostics platform that integrates automated sample preparation, analysis, and identification of disease relevant pathogens and antibiotic resistance markers. The company utilizes molecular diagnostics and informatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections to enhance patient outcomes, and to decrease the spread of infections caused by multidrug-resistant microorganisms. OpGen, Inc.

Frequently asked questions

What percentage of OpGen is owned by insiders or institutions?
Currently 0.578% of OpGen shares are held by insiders and 7.241% by institutions.
How many people work for OpGen?
Latest data suggests 91 work at OpGen.
When does the fiscal year end for OpGen?
OpGen's fiscal year ends in December.
Where is OpGen based?
OpGen's address is: 9717 Key West Avenue, Rockville, MD, United States, 20850
What is OpGen's ISIN number?
OpGen's international securities identification number is: US68373L3078
What is OpGen's CUSIP number?
OpGen's Committee on Uniform Securities Identification Procedures number is: 68373L109

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site